Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients
This study has been completed.
Sponsor:
AmpliMed Corporation
Information provided by:
AmpliMed Corporation
ClinicalTrials.gov Identifier:
NCT00327288
First received: May 17, 2006
Last updated: September 14, 2010
Last verified: September 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2008 |
| Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |